Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
2 days agoOther Barks & Bites for Friday, September 12: Novartis Loses Challenge to IRA Drug Price Negotiation Program; Lutnick Wants a Share of University IP Licensing; and EUIPO Announces First Copyright Conference
The Third Circuit affirmed dismissal of Novartis' constitutional challenges to the IRA Drug Price Negotiation Program, leaving Novartis as the latest pharmaceutical company to lose such a challenge.